DIS vs ESPR · P/E 16, rev $94.42B vs rev $332.3M
Walt Disney Company (DIS) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Bob Iger.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
DIS currently screens at market cap $175.14B and trailing P/E 16.1. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the DIS and ESPR stock pages for the full models.
Not investment advice.